SearchRecent comments
Democracy LinksMember's Off-site Blogs |
the covid saga.....AS OUR ILLUSTRIOUS AMERICAN "INTELLIGENCE" AGENCIES ARE STILL WORKING HARD TO FIND THE ORIGIN OF COVID (BATS — PANGOLINS — RACCOON DOGS — OR LABS [Ukrainian, Chinese, American?]) THE PANDEMIC WAS A BOON FOR PHARMACEUTICALS WHO MANUFACTURED VACCINES OF VARIOUS EFFICACITY, WITH THE EXPRESS BLESSING OF GOVERNMENTS FOR COMPULSORY VACCINATIONS, WITH NO RESPONSIBILITY FOR SIDE-EFFECS (AND THERE WERE MANY) SINCE PRESIDENT REAGAN ABOLISHED SUCH RESPONSIBILITY. VACCINE MANDATES BECAME PART OF A TACTIC BY GOVERNMENTS WORLDWIDE AND SOME STRANGE (MIS?) INFORMATION CAME TO LIGHT IN REGARD TO MANIPULATION OF DATA AND POOR LAB PRACTICES. (MORE TO COME IN COMMENTS BELOW) MEANWHILE: https://www.youtube.com/watch?v=BoyTQWJN29w
|
User login |
poor tests?......
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2635 (Published 02 November 2021)
Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Paul D Thacker reports
In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. “As I’ve said before, we are operating at the speed of science,” Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States.1
But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson (video 1), emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.
READ MORE:
https://www.bmj.com/content/375/bmj.n2635
SEE ALSO:
https://bmjmedicine.bmj.com/content/2/1/e000385
FREE JULIAN ASSANGE NOW....
impunity of research.....
https://www.youtube.com/watch?v=mq40DHOMoKM